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Background
Skeletal integrity requires continuous bone remodelling by
osteoblasts and osteoclasts, and thyroid hormone (TH) is a
key regulator of bone remodelling. Excess TH (hyperthyr-
oidism) causes net bone loss, resulting in osteoporosis and
increased fracture risk; lack of TH (hypothyroidism) also
increases fracture risk because bones become brittle from
decreased bone turnover [1]. TH stimulates bone forma-
tion and resorption through processes that are only partly
defined; it enhances osteoblast proliferation and differentia-
tion, and induces osteoblast production of the osteoclast
differentiation factor RANKL (receptor activator of nuclear
factor-B ligand). Nuclear TH receptors (THR-a and
THR-b) act as transcriptional regulators and generate the
hormone’s classic “genomic” effects [1]. In different cell
types, TH also has transcription-independent (“non-geno-
mic”) effects, including stimulation of the MEK/Erk and
PI3K/Akt/mTOR kinase cascades, but the molecular
mechanisms mediating these non-genomic effects are lar-
gely unknown.
Results
We found that physiological concentrations of 3,5,3’-
triiodo-L-thyronine (T3, 10-9 to 10-11M), but not reverse-
T3, rapidly increase NO production, and activate Src,
Erk, and Akt in osteoblasts. These TH effects required
THR-a, but were independent of THR–b. We identified
a novel, membrane-bound THR-a isoform that mediates
T3-induced Erk/Akt activation, but does not affect tran-
scription from TH response element-containing promo-
ters. Signalling via the newly-discovered THR-a isoform
was blocked by inhibitors of NO synthase, guanylate
cyclase (sGC), or protein kinase G (PKG), and was defec-
tive in endothelial NO synthase (eNOS)- or PKG II-defi-
cient osteoblasts. We showed previously that NO/cGMP
induce osteoblast proliferation through PKG II activation
of Src and Erk, and established a mechanism for Src acti-
vation by PKG II [2]. We now show that TH enhances
osteoblast proliferation and survival, and induces osteo-
calcin and fos family gene expression in a NO/cGMP/
PKG-dependent fashion via “non-genomic” activation of
Erk. In contrast, TH-induced expression of the osteoclast
regulator RANKL occurs independently of NO, suggest-
ing a classic “genomic” effect via nuclear THR-a. Consis-
tent with these results, treatment with the sGC activator
cinaciguat increased bone formation in hypothyroid
mice, without affecting osteoclast numbers.
Conclusion
We conclude that anabolic effects of TH in osteoblasts are
mediated predominantly by non-genomic TH signalling,
via activation of a novel, membrane-bound THR-a
isoform, with subsequent activation of eNOS, sGC, PKGII,
Src, Erk, and Akt. Our results are consistent with the
phenotype of THR-a knockout mice and the role of NO
in bone biology.
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